medigraphic.com
ISSN 1870-2821 (Print)
Organo Oficial de la Asociación Mexicana de Mastología

2020, Number 2

Next >>

Rev Mex Mastol 2020; 10 (2)

Epigenetics and breast cancer

Vásquez MI

Language: Spanish
References: 3
Page: 37-38
PDF size: 95.36 Kb.


Text Extraction

No asbtract.


REFERENCES

  1. Mendieta-Wejebe JE, Silva-Trujillo A, Bello M, Mendoza-Figueroa HL, Galindo-Alvarez NL, Albores A et al Exploring the biotransformation of N-(2-hydroxyphenyl)-2-propylpentanamide (an aryl valproic acid derivative) by CYP2C11, using in silico predictions and in vitro studies. J Pharm Pharmacol. 2020; 72 (7): 938-955.

  2. Martínez-Ramos F, Luna-Palencia GR, Vásquez-Moctezuma I, Méndez-Luna D, Fragoso-Vázquez MJ, Trujillo-Ferrara J et al. Derivative (S)-5- amino-2-(heptan-4-ylamino)-5-oxopentanoic Acid (Gln-VPA) on HDAC8 with biological evaluation in HeLa cells. Anticancer Agents Med Chem. 2016; 16 (11): 1485-1490.

  3. Luna-Palencia GR, Correa-Basurto J, Trujillo-Ferrara J, Meraz-Ríos MA, Vásquez-Moctezuma I. Epigenetic evaluation of N-(2-hydroxyphenyl)-2-propylpentanamide, a valproic acid aryl derivative with activity against HeLa cells. Curr Mol Pharmacol. 2020. doi: 10.2174/1874467213666200730113828. Online ahead of print.




2020     |     www.medigraphic.com